LaCroix’s Cross to Bear

A lawsuit of many flavors

The beverage company’s sparkling reputation has been tainted by a new lawsuit filed in early October.  It is the hope of the plaintiff that the case will reach class action status, as all LaCroix consumers are subjected to the apparent false advertising and deception of LaCroix’s parent company, the National Beverage Corporation.  The company markets all-natural ingredients in their products, however, the plaintiff alleges that the “natural essences” of LaCroix’s sparkling water are accompanied by synthetic and potentially harmful chemicals. Read more

IVC Filters Cannot Prevent Pending Lawsuits

Inferior_vena_cava_filter, by Wikimedia user BozMo, licensed by Creative Commons.

IVC filter

For every new medication or pharmaceutical device, there is a list of side effects. In the case of implantable vena cava (IVC) filters, C.R. Bard and Bard Peripheral Vascular, Inc. downplayed the risks involved in keeping the filters in bodies extending past a few months. The purpose of the IVC filters is to stop blood clots that may result in death. Despite the caution involved, filters were implanted for long-term use in the 1970s. In the early 2000’s, the FDA approved the short-term use of IVC filters. It was possible for patients to receive the filter implants, even if taking medication was an alternative remedy. Read more

Protein Powder Ripping Off Athletes

Day47:Weights

Bodybuilders Beware

Several companies have been on the receiving end of lawsuits claiming lack of protein in their supplements. A large number of the companies in this $7 billion industry are being accused of selling products with less protein content than what they advertise on the label. “Arnold Schwarzenegger Series Iron Mass, for instance, contains half the protein stated on its label, according to third party testing in one lawsuit”. FDA regulations require that content labels on all dietary supplements be accurate and not misleading to the consumers. In this case the expectation is that protein content be evaluated based on actual protein sources, not fillers such as amino acids.

Read More

Diet Pills Allegedly Land New York Woman in Mental Institution

Pills

Weight Loss Pills Cause NY Woman to Lose Her Mind.

Sainah Theodore is suing a Natural Health Food Center in East New York after she claimed a diet pill caused her to argue with strangers, stop her car in the middle of intersections, stab pillows and ultimately land her in a mental hospital. The weight loss pill initially caused her to sleep lightly and eventually resulted in six days of insomnia. Reports state that she sent her mother irrational and aggressive text messages and told a friend she was hearing voices. The pills are said to have been spiked with illegal stimulants that caused her to suffer from insomnia and act bizarrely. “I couldn’t believe all of this happened to me. It was a blur. I had no recollection of my behavior,” (Yaniv, 2014) said Theodore.

Read More

The Largest Drug-safety Settlement to Date

Decorative Scales of Justice in the Courtroom

Courtroom

Labeled by the U.S. Government as the largest drug-safety settlement to date with a generic drug manufacturer; Ranbaxy Laboratories has just pled guilty to three felony counts under the Food, Drug, and Cosmetic act, and four felony counts of of providing false statements to the United States Food and Drug Administration.

The company failed to conduct proper safety and quality tests of several drugs that were manufactured in the Indian plants. These generic drugs were manufactured in Paonta Sahib, and Dewas India. The major drugs involved in this case were the generic versions of Gabapentin, Sotret, and Ciprofloxacin. This is a great cause for concern because compared to the plants in the United States which are inspected by the F.D.A. once every two years, plants over seas are inspected about once every seven to thirteen years. It has been proven between June and August of 2007, certain batches of medications had tested positive for “unknown impurities” and had unreliable shelf lives. Ranbaxy waited two months until October of that year to report these impurities.

Read More